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Abstract
Introduction. The number of humans infected by Fasciola he-
patica is increasing worldwide. Humans can become accidental
hosts by ingesting drinking water or plants contaminated with
metacercariae. Case report. We reported a case of a 68-year-old
Serbian woman, in which the diagnosis of acute fasciolosis had
been established after serious diagnostic concerns. Based on
clinical picture (episodic right upper quadrant abdominal pain,
febrility and generalized body pain) and biochemical analyses
(high eosinophilia and high activity of alkaline phosphatase),
she was appointed as suspected to the acute fasciolosis. Stool
and duodenal aspirate exams were negative for Fasciola ova. In
the absence of adequate serologic diagnostic for fasciolosis in
Serbia, the diagnosis was confirmed using enzyme immunoas-
says and immunoblot at the Institute for Tropical Diseases in
Hamburg, Germany. Soon after triclabendazole was adminis-
tered, the symptoms disappeared and biochemical values re-
turned to normal. Conclusion. The diagnosis of human fas-
ciolosis may be problematic and delayed, especially in non en-
demic areas, because physicians rarely encounter this disease
and a long list of other diseases must be considered in the dif-
ferential diagnosis. The syndrome of eosinophilia, fever, and
right upper quadrant abdominal pain suggest acute fasciolosis.
Unclear source does not rule out fasciolosis.
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Apstrakt
Uvod. Broj ljudi zaraženih parazitom Fasciola hepatica je u
porastu širom sveta. þovek postaje sluÿajan domaýin uno-
šenjem infektivnih oblika, metacerkarija, kontaminiranom
vodom ili biljkama. Prikaz bolesnika. U radu je prikazana
68-godišnja bolesnica iz Srbije, kod koje je nakon dijagnos-
tiÿkog lutanja postavljena dijagnoza akutne fascioloze. Na
osnovu kliniÿke slike (bol pod desnim rebarnim lukom, feb-
rilnost, generalizovani bol), visoke eozinofilije i povišene
aktivnosti alkalne fosfataze u serumu posumnjalo se  na
akutnu fasciolozu. U fecesu i duodenalnom aspiratu nisu
naĀena jaja Fasciola hepatica. U nedostatku imunološke dijag-
nostike za fasciolozu u Srbiji, dijagnoza je postavljena na
osnovu prisustva specifiÿnih antitela imunoenzimskim tes-
tom i potvrĀena imunoblot metodom u Institutu za tropske
bolesti u Hamburgu, Nemaÿka. Leÿenje je sprovedeno pri-
menom triklabendazola, posle ÿega su se simptomi povukli,
a biohemijske vrednosti vratile u normalu. Zakljuÿak. Hu-
mana fascioloza može biti teška za dijagnostiku naroÿito u
neendemskim podruÿjima, gde kliniÿari retko pomisle na nju
i gde je duga lista bolesti koje treba iskljuÿiti u diferencijal-
noj dijagnostici. Sindrom eozinofilije, febrilnost i bolovi is-
pod desnog rebarnog luka sugerišu akutnu fasciolozu. Neja-
san izvor infekcije ne iskljuÿuje fasciolozu.
Kljuÿne reÿi:
fasciola hepatica; jetra, parazitne bolesti; ljudi;
dijagnoza; antihelmintici; leÿenje, ishod.
Introduction
Fasciolosis is a zoonotic infection caused by Fasciola
(F.) hepatica and gigantica. Human fasciolosis (HF) is en-
demic in some parts of South America, Africa, Eastern Asia
and Europe 
1, 2.
 Cases of human infection by F. hepatica are
not uncommon in European countries 
3 and can be predomi-
nantly found in France, Portugal, Spain and the former
USSR 
1, where fasciolosis is highly endemic
  in domestic
animals.
Humans can become accidental hosts of this parasite by
ingesting contaminated drinking water or plants in endemic
area. Infective metacercariae excyst in the duodenum and
larvae penetrate the wall of the small intestine, the peritoneal
cavity, the liver capsule, and pass through the liver tissue
into the biliary tract. High prevalence of HF does not neces-Volumen 71, Broj 2 VOJNOSANITETSKI PREGLED Strana 203
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sarily occur in areas where fasciolosis is a major veterinary
problem 
1, 3.
 Animal fasciolosis is enzootic to some parts of
former Yugoslavia, with no recent reports related to it. Sur-
vival of F. hepatica in this area is related to numerous animal
hosts, the presence of Lymnaea truncatula snails as the
original intermediate host, and also suitable environmental
and climatic factors. Recent studies indicate that sheep and
cattle are the main reservoir of F. hepatica in the territory of
the former Yugoslavia 
4, 5.
The last patient with fasciolosis was treated more than
20 years ago at the Clinic for Infectious and Tropical Dis-
eases in Belgrade. Human fasciolosis is a disease whose in-
cidence is difficult to determine in Serbia because it is not a
subject to mandatory reporting, it was not described in our
literature in the last several decades, there were no oral pres-
entations at medical meetings, diagnostics market is not de-
veloped and there are no effective drugs. There are also no
requirements for the procurement and registration of the spe-
cific drugs for fasciolosis, so we can conclude that it is rarely
diagnosed and cured.
Case report
A 68-year-old woman was admitted at the Clinic for In-
fectious and Tropical Diseases in Belgrade on March 10, 2005.
The patient was a pensioner from Belgrade, who spent the last
few months in a village near Trebinje in Herzegovina. Her last
travell, out of borders of former Yugoslavia, was in Canada,
two and a half years ago. She had a medical history of benign
breast node which was surgicaly removed in 1984. The patient
had been in a good health until the end of November 2004,
when she developed episodic right upper quadrant (RUQ) ab-
dominal pain which spread to the right shoulder, occasional
bloating, fever (39–40°C), shaking chills, occasional dizziness,
weakness and fatigue. This condition persisted and she was
admitted at the Department of Hematology of Clinical Hospi-
tal Center “Zvezdara”, Belgrade (from January 10 to February
9, 2005) with suspicion to eosinophilic leukemia. Detailed
clinical, laboratory and radiographic tests were performed. The
laboratory tests revealed mild normocytic normochromic ane-
mia, high eosinophilia, high serum activity of alkaline phos-
phatase (ALP), which maintained during all hospitalizations,
with normal alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) levels. Abdominal ultrasound (US)
showed the inhomogeneous right liver lobe. Computed tomog-
raphy (CT) scan showed hypodense changes (total diameter up
to 5 cm) in the right liver lobe below the diaphragm predomi-
nantly localized posteriorly and centrally that are partly flown
together. After application of contrast most of the changes re-
mained hypodense and only edges were imbibed by getting a
grape look appearance. The left liver lobe was homogeneous.
Two enlarged lymph nodes (up to 2 cm in size) were evident
in the retroperitoneum.
The diagnosis of malignancy was initially suspected
and for additional examination she was transfered to the De-
partment of Surgery (from February 9 to February 14, 2005).
Because the diagnosis of malignancy was initially consid-
ered, laparoscopic liver biopsy under visual control was per-
formed at the Department of surgery on February 14, 2005,
and before obtaining the histological diagnosis the patient
was released. Two fragments of the liver tissue were ob-
tained by biopsy. The first specimen showed less liver tissue
and largely fibrous tissue infiltrated by lymphocytes and nu-
merous eosinophils. The second specimen showed liver tis-
sue with fibrosis and small cells infiltration of the portal
fields. Some portal areas had a strong, almost serious prolif-
eration of connective tissue with bile ducts and blood ves-
sels. One part of the specimen showed nodules with strong
fibrosis and septa that form pseudo-tubules similar to inac-
tive cirrhosis. There was also a fibrous tissue containing bile
ducts and numerous blood vessels with thickened walls.
There were no signs of malignancy. A conclusion was that it
was focal nodular hyperplasia. After receiving a histopatho-
logical finding the patient was advised to continue testing at
the Clinic for Infectious and Tropical Diseases because of
her subjective complaints, fever and eosinophilia, the exis-
tence of non-specific histopathological lesions in the liver
and the history of travelling to tropical areas in the past.
Upon admission to our Clinic, her temperature was
37.8°C. Abdominal exam showed localized tenderness over
RUQ and a palpable liver border on the right costal margin.
The rest of the physical exam was unremarkable. On admis-
sion, hemoglobin level was 118 g/L, eritrocyte count was
3.96 × 10
12/L, the white-cell count was 13.5 × 10
9/L with
43.7% eosinophils, the platelet count was 243 × 10
9/L. The
erythrocyte sedimentation rate (ESR) was 60/90 mm/h and
serum biochemical analysis revealed the following values: Fe
7.1 μmol/L, ALP 174 U/l; ALT 16 U/l; AST 14 U/l L and al-
pha amylase 49 U/L. Total bilirubin was 7 μmol/L, fibrinogen
value was 5.6 g/L, C-reactive protein (CRP) 10 mg/L. Anti-
bodies to Brucella spp, HCV, HBV were not found. The re-
sults of tumor markers (CEA, CA 19.9, AFP) were within
normal range. Laboratory was controlled weekly (AST 20
U/L, ALT 26 U/L, than AST 57 U/L, ALT 68 U/L). The high-
est value for CRP was 15 mg/L, and fibrinogen 6.6 g/L.
In view of the persistent fever, hepatomegaly, and eosino-
philia serologic tests for a variety of parasites were requested.
Serology was negative for Toxoplasma gondii, Trichinella spi-
ralis, Echinococcus, Leishmania, Entamoeba histolytica, Schis-
tosoma, but Toxocara (T.) canis (1.27) and Cysticercus (1.21)
enzyme immunoassays (EIA) were mildly positive.
Chest radiographs showed no abnormalities. Abdominal
US on March 16 showed homogeneous liver of normal size,
with no visible focal changes. Two enlarged periportal hilar
lymph nodes (diameter 18 mm and 17 mm) with hypoechoic
appearance were detected.
The liver-spleen scintiscan on March 21, 2005, showed
mild hepatomegaly with track-like zones of hypofixation of
radiofarmaci (RF, radioactive colloids) in the right posterior
liver lobe. Liver and spleen scintigraphy showed the enlarged
liver, with straight upper edges. The contours of the upper part
of the right hepatic lobe were irregular and uneven. The distri-
bution of RF was non-homogeneous with the appearance of
zones of weaker binding of RF. Track-like zones of hypofixa-
tion of RF in the right posterior liver lobe were observed re-
sembling two oval recesses of the top of the right lobe.Strana 204 VOJNOSANITETSKI PREGLED Volumen 71, Broj 2
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It was unclear whether these changes were focal zones
or there was an extrahepatic origin of these recesses. The
spleen was mildly enlarged with tiny, oval discreet zones of
lower levels binding of RF. Because ultrasound did not show
focal liver lesions, radiologist recommended further investi-
gation (CT and scintigraphic control).
Abdominal CT (on April 4, 2005) demonstrated multi-
ple hypodense foci with subcapsular location on both sides
of the liver, partially merged (Figure 1). Repeated US on
April 11, 2005 showed irregular oval hyperechoic solitary
liver lesion, in the upper right lobe of the liver, near the con-
fluence of the right hepatic vein, 52 × 42 mm in size, without
a hypoechoic halo (Figure 2).
Fig. 1 – Abdominal computed tomography (CT) scan shows
multiple hypodense foci with subcapsular location.
Fig. 2 – Irregular oval hyperechoic solitary liver lesion
(52 × 42 mm in size), in the upper part of the right liver lobe.
A detailed re-evaluation with repeated investigation of
liver biopsy  (April 23, 2005)  revealed a histopathological
picture suggesting parasitic infection. In a small part of the
obtained material  were hepatocytes, and in the rest of  the
sample there was young granulation tissue infiltrated by eo-
sinophils and other inflammatory cells. Portal fields were
normal in size, easy to moderately infiltrated, mainly by eo-
sinophils, with a small number of other inflammatory cells.
Glycogenated nuclei were seen in the parenchyma. Inflam-
matory cells of the same type as those found in portal fields
were seen in the sinusoids.
Repeated stool and duodenal aspirate examinations were
negative for Fasciola eggs. Since the serology for T. canis was
not affirmative, along with the fact that Toxocara generally
gives changes in central nervous system and eyes, this type of
affection of the liver and bile ducts with high eosinophilia re-
sembled acute fasciolosis. Because acute fasciolosis was
highly suggested and serological diagnosis for fasciola was not
available in Serbia, the patient's serum was sent to the Institute
for Tropical Diseases in Hamburg, Germany. Serology to Wu-
chereria bancrofti, Schistosoma mansoni, Dirofilaria immitis
and Strongyloides stercoralis was negative but the EIA was
positive for Fasciola-specific IgG antibodies. The final diag-
nosis of fasciolosis was confirmed by immunoblot testing.
After the diagnosis was confirmed, triclabendazole
(Egaten
®, Novartis) was administered at the dose of 10
mg/kg for 1 day.
Control abdominal ultrasound on May 4, 2005, was un-
changed. Before the patient was discharged on May 5, 2005,
ESR was 52/84 mm/h, leukocytes 10.4 × 10
9/L with eosino-
philia 34%, platelets 227 × 10
9/L, AST 15 U/L, ALT 17 U/L,
ALP 125 U/L.
The patient appeared clinically well two weeks after the
treatment. At a 6 month follow-up examination, her eosino-
phil count, hematological and biochemical results were nor-
mal (ESR l5 mm/hour, CRP 6 mg/L, leukocytes 7,2 × 10
9/L,
eosinophilia l2%).
Discussion
We reported a case of acute HF of uncertain origin of
infection. Although the beginning of the disease coincides
with the patient's several months stay in Herzegovina, con-
sidering the fact that there were no reports of animal fascio-
losis in this area, we could not be sure if the infection was
positively acquired there. A source of infection was unclear,
too. It could be due to the consumption of improperly
washed fresh vegetables since the patient used to buy them
supplied in the green market with no defined product
sourcing or she could have been infected by chewing grass
contaminated with metacercaria or by contaminated water.
This is consistent with data about human infection in areas
where people do not have a history of eating watercress 
2.
The experimental results suggest that humans who consume
raw dishes prepared from fresh livers infected with immature
flukes could become infected with F. hepatica 
6,
 but our pa-
tient did not have these data in her history. It fits into the ex-
planation of Mas-Coma et al. 
1 about the existence of isolated
autochthonous, nonconstant cases 
7.
Infection with F. hepatica has a variable clinical presen-
tation depending on the stage of the disease. The syndrome of
eosinophilia, fever, and right abdominal upper quadrant pain,
without jaundice, hypodense liver lesions on CT, and an ap-
propriate exposure history (history of eating fresh vegetables
that may be improperly washed) suggests acute fasciolosis. A
negative history does not rule out fasciolosis. High ESR,
anaemia and leukocytosis with high eosinophilia (may be up to
70%) are frequent findings in infected individuals in the early
phase of the disease 
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sitic infections causing eosinophilia and/or similar symptoms
should be ruled out. Hypereosinophilic syndrome was rarely
diagnosed as Toxocara, Strongyliodes and Fasciola 
8. In this
case, the clinical presentation and liver problem indicate that
HF was probably the unique diagnosis. Because of the en-
demicity of toxocariosis and cysticercosis in Serbia, positive
serology for both infections was probably due to anamnestic
antibody response or a nonspecific antibody response. Ami-
notranspherase levels are usually in normal range or are only
minimally elevated, and bilirubin levels are typically in normal
range, as was the case with our patient. Saba et al. 
9 reported
28 patients with acute fasciolosis who predominantly had epi-
gastric pain, fatigue, fever and RUQ abdominal pain and ele-
vated eosinophilia, ALT level and acute-phase reactant in
laboratory findings. Eosinophilia in fasciolosis is striking and
almost always present 
9, 10.
  According to results of Haseeb et
al. 
11 high activity of ALP, as well as significantly high eo-
sinophilia and low hemoglobin, are the most significant labo-
ratory features of HF, as it was in our case.
Hepatic lesions are produced by migration of juvenile
Fasciola through liver in the invasive stage. Histologically,
they correspond to microabscesses and tunnel-like areas of
parenchymal necrosis 
12.
 Characteristic parenchymal lesions
are clearly demonstrated by imaging procedures. Imaging
techniques used for diagnosis of fasciolosis include radiol-
ogy, radioisotope scanning, US, CT scan or MRI that may
show the tunnels caused by the migrating young flukes or the
flukes in the biliary passages (chronic infection)
 7. The first
abdominal CT finding in our patient showing hypodense
clustered lesions in a periphery of the right lobe of the liver
and enlarged retroperitoneal lymph nodes was compatible
with hepatic phase of fasciolosis.
Han et al. 
13 reported the characteristic radiological
features in 5 patients with hepatic fasciolosis that involve
cluster of microabscesses arranged in track-like hypodense
lesions with subcapsular location, and a very slow evolution
of the lesion. Marcos et al. 
14 further reported  hepatomegaly
as a common finding on abdominal CT scan in patients with
fasciolosis. First abdominal CT finding in our patient was
compatible with hepatic phase of fasciolosis, but radiologists
were not familiar with findings of this disease.
 Typical find-
ings on US, which should be absolutely performed as initial
assessment procedure, facilitate the diagnosis.
Magnetic resonance imaging (MRI) reflects the extent
of the lesions better than CT in the earlier stage. In the late
parenchymal phase, the extent of the lesions on the speci-
mens is well correlated with both CT scan and MRI 
15. Peri-
portal lymph node enlargement or lymphadenopathy is help-
ful in the diagnosis 
16,
 which was the case in our patient.
The biliary phase is usually asymptomatic, and only
intermittent cholangitis may be the prominent sign, but it is
rarely reported that it can lead to extrahepatic obstruction
and cholestasis 
17.
The diagnosis of fasciolosis is complex and requires
application of both direct an indirect methods of diagnostics.
Diagnosis of F. hepatica infection has traditionally relied on
detecting the presence of eggs in fecal samples or bile
specimens, but
  this method is unreliable and complicated.
Negative stool examinations do not rule out fasciolosis. A
period of at least 3 to 4 months is necessary for F. hepatica
flukes to attain sexual
 maturity in humans 
18. Our patient was
admitted to our Clinic with a 3-month history of illnes. This
can be the reason why the stool examination was negative.
Human is generally believed to be a non-suitable host and
the possibility of hepatic infections by flukes which are un-
able to attain maturity, cannot be disregarded 
19.
At present,
 the routine diagnosis of HF is based on the
detection
 of antifluke antibodies in the serum. Specific anti-
bodies to Fasciola may be detectable within 2 to 4 weeks
after infection, which is 5 to 7 weeks before eggs appear in
stool. Immunological techniques present the advantages of
being applicable during all phases of the disease, but espe-
cially during the acute phase. This is important in areas
where HF is rare 
1, such as in Serbia. Although, early diag-
nosis of fasciolosis is performed mainly on serum assay 
10,
for rare parasitic infection, such as fasciolosis, there is a lack
of registered diagnostic tests in Serbia. The current test of
choice for immunodiagnostic of human F. hepatica infection
is EIA 
20 combined with confirmation of positives by immu-
noblot 
14  with a sensitivity of 100% and a specificity of
97.8% 
21. Since signs and symptoms of fasciolosis may be
confused with a wide variety of disorders, including hepato-
biliary and extrahepatobiliary diseases (hepatitis, cholecystis,
cholangitis, liver abscess, brucellosis, leishmaniosis, schisto-
somiosis and primary and secondary hepatobiliary malignan-
cies)
 16,
 diagnosis and treatment are often problematic and
delayed, which was the case in our patient.
Many drugs have been used to treat fasciolosis with
variable success 
14, 22–24. The first-line treatment of HF is with
a single oral dose (10 mg/kg) of triclabendazole which is
highly effective against mature and immature flukes, safe,
and easy to use 
2, 14, 25.
 Treatment should be repeated when a
single dose fails to cure the infection 
10. A single dose of tri-
clabendazole was successful and without side effects in our
patient. Albendazole, widely used in animal fasciolosis, is
ineffective against human infections 
22, as it was the case in
the presented patient.
Conclusion
Human fasciolosis can be very difficult to diagnose, be-
cause it sometimes appears with atypical and severe clinical
presentation. Problematic and delayed diagnosing is especially
risky in nonendemic areas where clinicians are not familiar
with this disease. The syndrome of eosinophilia, fever, and
RUQ abdominal pain without jaundice; liver damage, which is
manifested by a high activity of liver enzymes and hypodense
liver lesions on CT, including an appropriate exposure history,
suggest acute fasciolosis. Unclear history does not rule out
fasciolosis. Fortunately, with the exact diagnosis simple ther-
apy with triclabendazole is extremely effective.
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